Mercer Global Advisors
MRVI icon

Mercer Global Advisors’s Maravai LifeSciences MRVI Stock Holding History

Mercer Global Advisors’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-19,345
Closed -$168K – 2017
2024
Q1 		$168K Sell
19,345
-1,808
-9% -$12.2K ﹤0.01% 1813
2023
Q4 		$139K Buy
21,153
+76
+0.4% +$491 ﹤0.01% 1881
2023
Q3 		$211K Buy
21,077
+6,656
+46% +$73.1K ﹤0.01% 1736
2023
Q2 		$179K Buy
14,421
+3,944
+38% +$53.2K ﹤0.01% 1755
2023
Q1 		$147K Buy
+10,477
New +$150K ﹤0.01% 1779

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Mercer Global Advisors's MRVI Position: Q2 2024 in Review

Mercer Global Advisors sold out of Maravai LifeSciences (MRVI) in Q2 2024, closing a stake of 19,345 shares — an estimated $168K sold.

Mercer Global Advisors first reported a position in MRVI in Q1 2023 and held it in 5 quarters. The position peaked at $211K in Q3 2023. 206 funds tracked by Wall St. Rank hold MRVI as of Q2 2024.

  • Mercer Global Advisors reported no remaining Maravai LifeSciences position as of Q2 2024 after selling out during the quarter.
  • Mercer Global Advisors sold 19,345 Maravai LifeSciences shares in Q2 2024, an estimated $168K.
  • Mercer Global Advisors first reported a position in Maravai LifeSciences in Q1 2023 and held it in 5 quarters.
  • Mercer Global Advisors's Maravai LifeSciences position peaked at $211K in Q3 2023.
  • 206 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2024.

Based on Mercer Global Advisors's 13F filing for Q2 2024, filed 12 Aug 2024.